Stock Market Forecast Based on a Self-learning Algorithm: Returns up to 103.14% in 14 Days

Stock Market Forecast

The Fundamental Package includes our algorithmic stock market forecast for stocks screened by fundamental criteria. Our algorithms help you find best opportunities for both long and short positions for the stocks within each fundamental screen. The stocks are selected according to five basic valuation categories:

  • P/E (price to earnings ratio)
  • PEG (price/earnings to growth ratio)
  • price-to-book ratio
  • price-to-sales ratio
  • short ratio

fundamentals
Package Name: Fundamental – High Price-to-Sales ratio Stocks
Recommended Positions: Long
Forecast Length: 14 Days (3/31/2020 – 4/14/2020)
I Know First Average: 17.76%
Stock Market Forecast
Stock Market Forecast chart

The algorithm correctly predicted 9 out 10 of the suggested trades in the Fundamental – High Price-to-Sales ratio Stocks Package for this 14 Days forecast. The prediction with the highest return was PSTI, at 103.14%. OSUR and AXDX saw outstanding returns of 18.16% and 13.92%. The package had an overall average return of 17.76%, providing investors with a premium of 9.41% over the S&P 500’s return of 8.35% during the same period.

Pluristem Therapeutics Inc., incorporated on May 10, 2001, is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company’s lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. The Company’s operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company’s products include PLX-PAD and PLX R18. The Company’s PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company’s PLX products are administered using a standard needle and syringe. The Company’s PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women’s health diseases.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.